Retinoic acid is a negative regulator of the Epstein-Barr virus protein (BZLF1) that mediates disruption of latent infection.
about
Epstein-Barr virus lytic infection induces retinoic acid-responsive genes through induction of a retinol-metabolizing enzyme, DHRS9Functional antagonism between the retinoic acid receptor and the viral transactivator BZLF1 is mediated by protein-protein interactions.The Epstein-Barr virus lytic cycle activator Zta interacts with methylated ZRE in the promoter of host target gene egr1.The nuclear and adherent junction complex component protein ubinuclein negatively regulates the productive cycle of Epstein-Barr virus in epithelial cellsPhysical and functional interaction of the Epstein-Barr virus BZLF1 transactivator with the retinoic acid receptors RAR alpha and RXR alpha.The Epstein-Barr virus bZIP transcription factor Zta causes G0/G1 cell cycle arrest through induction of cyclin-dependent kinase inhibitorsRAZ, an Epstein-Barr virus transdominant repressor that modulates the viral reactivation mechanismFunctional and physical interaction between p53 and BZLF1: implications for Epstein-Barr virus latency.The bZIP transactivator of Epstein-Barr virus, BZLF1, functionally and physically interacts with the p65 subunit of NF-kappa BReciprocal regulation of the Epstein-Barr virus BamHI-F promoter by EBNA-1 and an E2F transcription factor.Inhibition of Epstein-Barr virus reactivation by the flavonoid apigenin.Switching of EBV cycles between latent and lytic states.Regulation of Epstein-Barr virus reactivation from latency.Epstein-Barr virus lytic replication is controlled by posttranscriptional negative regulation of BZLF1.The Epstein-Barr virus Rta protein activates lytic cycle genes and can disrupt latency in B lymphocytesAmino-acid change in the Epstein-Barr-virus ZEBRA protein in undifferentiated nasopharyngeal carcinomas from Europe and North Africa.The amino-terminal C/H1 domain of CREB binding protein mediates zta transcriptional activation of latent Epstein-Barr virus.Analysis of host gene expression changes reveals distinct roles for the cytoplasmic domain of the Epstein-Barr virus receptor/CD21 in B-cell maturation, activation, and initiation of virus infection.Activation domain requirements for disruption of Epstein-Barr virus latency by ZEBRA.Animal membrane receptors and adhesive molecules.Association of Epstein-Barr virus infection with p53 protein accumulation but not bcl-2 protein in nasopharyngeal carcinoma.Inhibition of Epstein-Barr virus reactivation in nasopharyngeal carcinoma cells by dietary sulforaphane.Vitamin A and systemic inflammation as protective factors in multiple sclerosis.
P2860
Q28284628-390F8A8E-FD30-4734-9F82-2C90FF69EF92Q33662787-C61521C5-CA31-4D22-BD5D-8D86400985A6Q33910725-951E7BC7-BAA6-4AB2-B0C5-0B819E51CA10Q34485205-1D063E00-2AD4-46B3-977D-7A107F1AF388Q34751026-FDAC8CB6-CF19-479A-8EF6-7616D1253CF2Q35851139-2A5DA7E3-07CF-4AF3-8EAE-5AE9323C859CQ36630074-8B188BB4-8662-471B-917D-9B8D3040B22DQ36648185-53E4CF05-4EDB-4ED4-8FEE-3A8D27201283Q36648227-8FCE04A9-F145-452F-987F-22802BA53FC2Q36668946-9B8C99DF-0D32-4119-A8A3-B5AB915F72A3Q37566280-30482DB7-AA60-44AE-8CC6-5FA9138262DBQ38171455-3BF7D16B-5970-4A0D-AF26-73BACE9D6A8EQ38208532-FB0CFC9C-131C-4984-BD60-9C23932DF5EFQ38296954-5537F023-B6BB-47A3-855A-DF072ADC3CDBQ38333495-6CE847E4-3656-4437-8F28-B9C318E2FE06Q39034599-DA3EDA6C-0C9B-4F60-BCB0-252FD6243801Q39444671-E683ADDD-067C-49E4-B7F3-96A0C3B29FD3Q39547392-E2CF540C-ADCC-41C6-B4CF-C46A07FD6D4AQ39880831-624C802F-CEFA-4AFD-8300-0959CB9215F0Q41506599-71A56771-661A-4717-A625-590DABE11921Q41650259-721E521F-3FDF-4BFC-AFA5-94BF25FC08CAQ42717841-FD3C40F3-6C49-46B6-96AE-B255A0067BC1Q46105413-79CCD2C1-0D08-4589-9209-67A070A13686
P2860
Retinoic acid is a negative regulator of the Epstein-Barr virus protein (BZLF1) that mediates disruption of latent infection.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh
1993年學術文章
@zh-hant
name
Retinoic acid is a negative re ...... isruption of latent infection.
@ast
Retinoic acid is a negative re ...... isruption of latent infection.
@en
type
label
Retinoic acid is a negative re ...... isruption of latent infection.
@ast
Retinoic acid is a negative re ...... isruption of latent infection.
@en
prefLabel
Retinoic acid is a negative re ...... isruption of latent infection.
@ast
Retinoic acid is a negative re ...... isruption of latent infection.
@en
P2093
P2860
P356
P1476
Retinoic acid is a negative re ...... isruption of latent infection.
@en
P2093
P2860
P304
P356
10.1073/PNAS.90.9.3894
P407
P577
1993-05-01T00:00:00Z